events TEAEs

Related by string. * eventing . EVENTS . EVENT . Events . Eventing . Event . eventer . eVent . eVENT . Eventer . evented : IN NO EVENT . EVENT GIVING RISE TO . Petersen Events Center . Corporate Event Announcement . shared Events Calendar . event shall AME . SYS CON Events . event . Events venues calendars . Paper Event Calendar . WSOP Main Event . FDA MedWatch Adverse Event . events / : TEAEs * *

Related by context. Frequent words. (Click for all words.) 69 treatment emergent adverse 68 Lactic acidosis 68 Adverse events 67 hypomagnesemia 67 laboratory abnormalities 66 events SAEs 66 TYSABRI treated 65 discontinuations 65 diarrhea nausea vomiting 65 events AEs 65 Adverse reactions 64 cerebrovascular events 64 renal toxicity 63 neurologic symptoms 63 discontinuations due 63 thromboembolic events 63 thrombotic events 62 leukopenia 62 sulfasalazine 62 voriconazole 62 enalapril 62 hepatotoxicity 62 dyspareunia 62 hypoglycemic events 62 pruritis 62 nasopharyngitis 62 concomitant medications 62 adverse reactions observed 61 angioedema 61 hypercalcemia 61 peripheral edema 61 endophthalmitis 61 SAEs 61 elevated liver enzymes 61 Lamictal XR 61 Thrombocytopenia 61 levetiracetam 61 bone marrow suppression 61 mycophenolate mofetil 61 QT prolongation 60 COPD exacerbations 60 hypocalcemia 60 lamotrigine 60 renal insufficiency 60 thromboembolism 60 optic neuropathy 60 acneform rash 60 Neutropenia 60 plus methotrexate 60 Exclusion criteria 60 coadministration 60 fluoxetine Prozac 60 Urinary tract infections 60 renal impairment 60 #mg/day [001] 60 ziprasidone 60 metabolic acidosis 60 myocardial infarctions 59 virologic failure 59 PREZISTA r 59 unknown etiology 59 GSK# [001] 59 aseptic meningitis 59 lymphopenia 59 sensory neuropathy 59 thromboembolic 59 anticholinergics 59 Navelbine 59 mg QD 59 verapamil 59 severe renal impairment 59 lactic acidosis 59 arthralgia 59 myelosuppression 59 cabergoline 59 tamsulosin 59 febrile neutropenia 59 P = .# 59 mg BID 59 QTc 58 infusion reactions 58 gout flares 58 pheochromocytoma 58 venous thromboembolic events 58 onset seizures 58 olmesartan 58 neuropsychiatric symptoms 58 anticonvulsants 58 Secondary endpoints 58 chlorambucil 58 gemfibrozil 58 lacosamide 58 hypokalemia 58 ketoconazole 58 AVELOX 58 stable angina 58 abdominal pain diarrhea 58 placebo p = 58 valacyclovir 58 tumor lysis syndrome 58 angiotensin converting enzyme inhibitors

Back to home page